A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With Obesity

Stopped This study was terminated due to expired drug with possibility of re-starting in the future.

Conditions

• Obesity
• Insulin Resistance

Interventions

• DRUG: Fenretinide
• DRUG: Placebo

Sponsor

University of California, San Diego